Lack of Liver X Receptors Leads to Cell Proliferation in a Model of Mouse Dorsal Prostate Epithelial Cell

被引:21
作者
Dufour, Julie [1 ,2 ,3 ,4 ]
Pommier, Aurelien [1 ,2 ,3 ,4 ]
Alves, Georges [1 ,2 ,3 ,4 ]
De Boussac, Hugues [1 ,2 ,3 ,4 ]
Lours-Calet, Corinne [1 ,2 ,3 ,4 ]
Volle, David H. [1 ,2 ,3 ,4 ]
Lobaccaro, Jean-Marc A. [1 ,2 ,3 ,4 ]
Baron, Silvere [1 ,2 ,3 ,4 ]
机构
[1] Univ Clermont Ferrand, Clermont Univ, Clermont Ferrand, France
[2] CNRS, UMR GReD 6293, Aubiere, France
[3] INSERM, UMR GReD 1103, Aubiere, France
[4] Ctr Rech Nutr Humaine Auvergne, Clermont Ferrand, France
关键词
FATTY-ACID SYNTHASE; CANCER-CELLS; HUMAN HEALTH; LXR-ALPHA; MICE; CHOLESTEROL; EXPRESSION; ANDROGEN; GROWTH; PROGRESSION;
D O I
10.1371/journal.pone.0058876
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Recent studies underline the implication of Liver X Receptors (LXRs) in several prostate diseases such as benign prostatic hyperplasia (BPH) and prostate cancer. In order to understand the molecular mechanisms involved, we derived epithelial cells from dorsal prostate (MPECs) of wild type (WT) or Lxr alpha beta-/- mice. In the WT MPECs, our results show that LXR activation reduces proliferation and correlates with the modification of the AKT-survival pathway. Moreover, LXRs regulate lipid homeostasis with the regulation of Abca1, Abcg1 and Idol, and, in a lesser extent, Srebp1, Fas and Acc. Conversely cells derived from Lxr alpha beta-/- mice show a higher basal phosphorylation and consequently activation of the survival/proliferation transduction pathways AKT and MAPK. Altogether, our data point out that the cell model we developed allows deciphering the molecular mechanisms inducing the cell cycle arrest. Besides, we show that activated LXRs regulate AKT and MAPK transduction pathways and demonstrate that LXRs could be good pharmacological targets in prostate disease such as cancer.
引用
收藏
页数:10
相关论文
共 24 条
[1]   Chemical inhibition of Acetyl-CoA carboxylase induces growth arrest and cytotoxicity selectively in cancer cells [J].
Beckers, Annelies ;
Organe, Sophie ;
Tinunermans, Leen ;
Scheys, Katryn ;
Peeters, Annelies ;
Brusselmans, Koen ;
Verhoeven, Guido ;
Swinnen, Johannes V. .
CANCER RESEARCH, 2007, 67 (17) :8180-8187
[2]   Expression signature of the mouse prostate [J].
Berquin, IM ;
Min, YN ;
Wu, RP ;
Wu, H ;
Chen, YQ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (43) :36442-36451
[3]   Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR [J].
Calkin, Anna C. ;
Tontonoz, Peter .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2012, 13 (04) :213-224
[4]   Modulation of liver X receptor signaling as novel therapy for prostate cancer [J].
Chuu, Chih-Pin ;
Kokontis, John M. ;
Hiipakka, Richard A. ;
Liao, Shutsung .
JOURNAL OF BIOMEDICAL SCIENCE, 2007, 14 (05) :543-553
[5]   Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist [J].
Chuu, Chih-pin ;
Hiipakka, Richard A. ;
Kokontis, John M. ;
Fukuchi, Junichi ;
Chen, Rou-Yu ;
Liao, Shutsung .
CANCER RESEARCH, 2006, 66 (13) :6482-6486
[6]   Liver X receptors regulate adrenal cholesterol balance [J].
Cummins, Carolyn L. ;
Volle, David H. ;
Zhang, Yuan ;
McDonald, Jeffrey G. ;
Sion, Benoit ;
Lefrancois-Martinez, Anne-Marie ;
Caira, Francoise ;
Veyssiere, Georges ;
Mangelsdorf, David J. ;
Lobaccaro, Jean-Marc A. .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (07) :1902-1912
[7]   SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression [J].
Ding, Zhihu ;
Wu, Chang-Jiun ;
Chu, Gerald C. ;
Xiao, Yonghong ;
Ho, Dennis ;
Zhang, Jingfang ;
Perry, Samuel R. ;
Labrot, Emma S. ;
Wu, Xiaoqiu ;
Lis, Rosina ;
Hoshida, Yujin ;
Hiller, David ;
Hu, Baoli ;
Jiang, Shan ;
Zheng, Hongwu ;
Stegh, Alexander H. ;
Scott, Kenneth L. ;
Signoretti, Sabina ;
Bardeesy, Nabeel ;
Wang, Y. Alan ;
Hill, David E. ;
Golub, Todd R. ;
Stampfer, Meir J. ;
Wong, Wing H. ;
Loda, Massimo ;
Mucci, Lorelei ;
Chin, Lynda ;
DePinho, Ronald A. .
NATURE, 2011, 470 (7333) :269-+
[8]   Oxysterol receptors, AKT and prostate cancer [J].
Dufour, Julie ;
Viennois, Emilie ;
De Boussac, Hugues ;
Baron, Silvere ;
Lobaccaro, Jean-Marc .
CURRENT OPINION IN PHARMACOLOGY, 2012, 12 (06) :724-728
[9]  
Esquenet M, 1996, PROSTATE, V28, P182, DOI 10.1002/(SICI)1097-0045(199603)28:3<182::AID-PROS5>3.0.CO
[10]  
2-H